URBN Reports Record Q3 Sales and Income GlobeNewswire November 25, 2025 PHILADELPHIA, Nov. 25, 2025 (GLOBE NEWSWIRE) — Urban Outfitters, Inc. (NASDAQ:URBN), a leading lifestyle products and services company which operates a portfolio of global consumer brands including the Anthropologie, Free People, FP Movement, Urban Outfitters and Nuuly brands, today announced record net income of […]

Talen Energy Completes Freedom and Guernsey Acquisitions Expands and Enhances Portfolio with 2.9 Gigawatts of Highly Efficient Natural Gas-Fired PJM Assets GlobeNewswire November 25, 2025 HOUSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) — Talen Energy Corporation (“Talen,” “the Company,” “we,” or “our”) (NASDAQ: TLN), a leading independent power producer, today announced that it has completed the

Workhorse Shareholders Approve Merger with Motiv Electric Trucks GlobeNewswire November 25, 2025 CINCINNATI, Nov. 25, 2025 (GLOBE NEWSWIRE) — Workhorse Group, Inc. (Nasdaq: WKHS) (“Workhorse” or “the Company”), an American technology company focused on pioneering the transition to zero-emission commercial vehicles, today announced that at the 2025 Annual Meeting of Shareholders (the “Annual Meeting”) held

Ambarella, Inc. Announces Third Quarter Fiscal Year 2026 Financial Results GlobeNewswire November 25, 2025 SANTA CLARA, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) — Ambarella, Inc. (NASDAQ: AMBA), an edge AI semiconductor company, today announced financial results for its third quarter of fiscal year 2026 ended October 31, 2025. Revenue for the third quarter of fiscal

nCino to Participate in Upcoming Investor Events GlobeNewswire November 25, 2025 WILMINGTON, N.C., Nov. 25, 2025 (GLOBE NEWSWIRE) — nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, today announced its participation in the following investor conferences: Raymond James 2025 TMT and Consumer ConferencePresentation: Tuesday December 9, at 11:20 a.m. ET Barclays

Surrozen to Present at Upcoming Healthcare Investor Conferences GlobeNewswire November 25, 2025 SOUTH SAN FRANCISCO, Calif., Nov. 25, 2025 (GLOBE NEWSWIRE) — Surrozen, Inc. (“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye diseases, today announced that Company management will

Allegro MicroSystems to Present at the 53rd Annual Nasdaq Investor Conference held in Association with Morgan Stanley Wednesday, December 10, 2025 GlobeNewswire November 25, 2025 MANCHESTER, N.H., Nov. 25, 2025 (GLOBE NEWSWIRE) — Allegro MicroSystems, Inc. (“Allegro”) (Nasdaq: ALGM), a global leader in power and sensing semiconductor solutions for motion control and energy efficient systems,

FibroBiologics Announces Closing of $1.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules GlobeNewswire November 25, 2025 HOUSTON, Nov. 25, 2025 (GLOBE NEWSWIRE) — FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics” or the “Company”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures for

Nasdaq Announces Mid-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date November 14, 2025 GlobeNewswire November 25, 2025 NEW YORK, Nov. 25, 2025 (GLOBE NEWSWIRE) — At the end of the settlement date of November 14, 2025, short interest in 3,414 Nasdaq Global MarketSM securities totaled 14,632,128,542 shares compared with 14,079,841,205 shares

LENZ Therapeutics to Present at Upcoming Investor Conferences GlobeNewswire November 25, 2025 SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) — LENZ Therapeutics, Inc. (Nasdaq: LENZ or “LENZ” or the “Company”), a pharmaceutical company focused on the commercialization of VIZZ(TM) (aceclidine ophthalmologic solution) 1.44%, the first and only FDA-approved aceclidine-based eye drop for the treatment of